Abstract
The pharmacokinetics and pharmacodynamics of enalapril, an angiotensin converting enzyme inhibitor, are reported to vary with the time of administration. The present study was undertaken to examine whether the effect of enalapril on plasma bradykinin (BK), substance P and prostaglandin E2 (PGE2), which are likely to be involved in the mechanism of enalapril-induced cough, might also be affected by its time of administration. Enalapril 5 mg or placebo was given orally at 10:00 h (day trial) or 22:00 h (night trial) to 12 patients with essential hypertension. Serum concentrations of total drug (enalapril + enalaprilat, its active metabolite) during the day and night trials did not differ significantly at any time. However, serum enalaprilat tended to be higher and its maximum concentration greater in the day trial than in the night trial. Blood pressure 24 h after administration of enalapril was reduced at 22:00 h, but not at 10:00 h. Plasma BK tended to increase following enalapril administration at 10:00 h, but not at 22:00 h. Remarkable increases in plasma BK were observed in two patients in the day trial and one of them also complained of cough. However, no such increase in plasma BK or subsequent adverse effect were recorded...Continue Reading
Citations
Jan 1, 1994·Life Sciences·A FujimuraA Ebihara
Sep 30, 2008·International Journal of Clinical Practice·L-L ZhuS Zeng
Oct 20, 2012·Chronobiology International·Ramón C HermidaFrancesco Portaluppi
May 21, 2015·Clinical and Experimental Hypertension : CHE·Atsuhisa Sato, Seiichi Fukuda
Apr 20, 2005·Clinical and Experimental Hypertension : CHE·Masami Ohmori, Akio Fujimura
May 1, 1998·Chronobiology International·K SakamotoA Fujimura
Dec 15, 2015·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Ramón C HermidaFrancesco Portaluppi
Mar 27, 2001·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·H OkumuraT Rikihisa
Feb 13, 2002·Journal of Human Hypertension·H Lind, L Edvinsson
Jun 28, 2008·American Journal of Physiology. Gastrointestinal and Liver Physiology·Hirofumi SaitoKen-Ichi Inui
Oct 12, 2010·American Journal of Hypertension·Ramón C HermidaMichael H Smolensky
Sep 18, 2020·Expert Opinion on Drug Metabolism & Toxicology·Ramón C HermidaJosé R Fernández
Oct 7, 2011·The Cochrane Database of Systematic Reviews·Ping ZhaoZhengrong Wang
Jun 20, 2013·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Akio Fujimura